Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Utz, J.
Right arrow Articles by Edell, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Utz, J.
Right arrow Articles by Edell, E.

Chest, Vol 104, 1012-1016, Copyright © 1993 by American College of Chest Physicians


ARTICLES

The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma

JP Utz, AM Patel and ES Edell
Division of Thoracic Diseases and Internal Medicine, Mayo Medical Center, Rochester, Minn. 55905.

Metastatic spread to subcarinal lymph nodes in patients with bronchogenic carcinoma generally indicates unresectability. Transcarinal needle aspiration of the main carina (TCNA) has been used to obviate the need for more invasive procedures, particularly thoracic surgery. Of 510 transbronchial needle aspirations performed at our institution from 1983 to 1991, 88 (17 percent) were from the main carina in patients with bronchogenic carcinoma. We reviewed these 88 TCNA procedures to assess our experience with TCNA in the staging of lung cancer. The TCNA results were positive in 32 of 88 (36 percent) patients (20 non-small-cell cancers, 12 small-cell lung cancers). Following bronchoscopy, TCNA was the only evidence of unresectability in all 20 patients with non-small-cell lung cancer and was the only mode of diagnosis in 5 of 12 (42 percent) patients with small-cell lung cancer. Thirteen patients with non-small-cell lung cancer and positive TCNA also had positive bronchial secretion cytologic studies. Five of these patients had further subcarinal sampling and in all cases metastatic involvement was confirmed. TCNA was positive in 29 of 67 (43 percent) patients with radiographic evidence of mediastinal adenopathy. Of the remaining 38 patients with radiographic evidence of mediastinal adenopathy and negative TCNA results, 23 patients had further mediastinal sampling with mediastinoscopy or thoracotomy and in all cases mediastinal spread of cancer was established. Nineteen of 58 (33 percent) patients with an endoscopically normal-appearing main carina had a positive TCNA, while 13 of 30 (43 percent) patients with broadening or widening of the main carina had positive TCNA results. There were no complications. We conclude that TCNA is often a safe and useful staging modality in patients with bronchogenic carcinoma.


This article has been cited by other articles:


Home page
JCOHome page
D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al.
American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003
J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353.
[Full Text] [PDF]


Home page
ChestHome page
G. Schreiber and D. C. McCrory
Performance Characteristics of Different Modalities for Diagnosis of Suspected Lung Cancer: Summary of Published Evidence
Chest, January 1, 2003; 123(1_suppl): 115S - 128S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. P. Rivera, F. Detterbeck, and A. C. Mehta
Diagnosis of Lung Cancer: The Guidelines
Chest, January 1, 2003; 123(1_suppl): 129S - 136S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. M. Toloza, L. Harpole, F. Detterbeck, and D. C. McCrory
Invasive Staging of Non-small Cell Lung Cancer: A Review of the Current Evidence
Chest, January 1, 2003; 123(1_suppl): 157S - 166S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Chin Jr., T. W. McCain, M. A. Lucia, J. O. Cappellari, N. E. Adair, J. F. Lovato, D. P. Dunagan, M. A. Brooks, H. P. Clark, and E. F. Haponik
Transbronchial Needle Aspiration in Diagnosing and Staging Lung Cancer: How Many Aspirates Are Needed?
Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 377 - 381.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Patelli, L. L. Agli, V. Poletti, R. Trisolini, A. Cancellieri, N. Lacava, F. Falcone, and M. Boaron
Role of fiberscopic transbronchial needle aspiration in the staging of N2 disease due to non-small cell lung cancer
Ann. Thorac. Surg., February 1, 2002; 73(2): 407 - 411.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. N. Goldberg, V. Raptopoulos, P. M. Boiselle, K. J. Edinburgh, and A. Ernst
Mediastinal Lymphadenopathy: Diagnostic Yield of Transbronchial Mediastinal Lymph Node Biopsy with CT Fluoroscopic Guidance-Initial Experience
Radiology, September 1, 2000; 216(3): 764 - 767.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. J. HARKIN, C. CIOTOLI, D. J. ADDRIZZO-HARRIS, D. P. NAIDICH, J. JAGIRDAR, and W. N. ROM
Transbronchial Needle Aspiration (TBNA) in Patients Infected with HIV
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1913 - 1918.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American College of Chest Physicians.